Network News

New innovation platform with significant involvement from Heidelberg University is one of Europe’s most important start-up centers In its first year of existence, the NXTGN Startup Factory has already become one of Europe’s most important start-up centers. As an innovation platform, the strategic alliance of Baden-Württemberg universities and private-sector partners, with significant participation from Heidelberg […]

Heidelberg, Germany, 17 February 2026 ­- BioMed X, a leading innovation hub for pharma headquartered in Heidelberg, hosted the first XFem Labs Pitch & Connect event on February 13th in Heidelberg, marking the official launch of XFem Labs, its new Women’s Health R&D Accelerator established with support from the Gates Foundation. The purpose of this initiative is to build a world-class women’s health […]

The National Medical Products Administration (NMPA) in China has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic device in China. It is intended as a companion diagnostic to identify patients with MSI-high (MSI-H) solid tumors for treatment with KEYTRUDA® (pembrolizumab), the anti-PD-1 therapy from Merck & Co., Inc., […]

5 neue Startups: ONOX, aimed analytics, Recarbox, FORMIC, showroom.fm Es ist wieder soweit – neue Startups stehen in den Startlöchern! Hier sind einige spannende junge Unternehmen, die man kennen sollte. Heute werfen wir einen Blick auf diese Neugründungen: ONOX, aimed analytics, Recarbox, FORMIC und showroom.fm. deutsche-startups.de stellt heute erneut eine Auswahl junger Startups vor, die […]

Bridgetown, Barbados, January 27, 2026 – BioMed X, a leading innovation hub for pharma, today announced the launch of its first research project in partnership with the Government of Barbados and with support from the European Union’s PharmaNext Programme. The new global call for research proposals, entitled “AI-Enabled Therapy of Early Diabetic Kidney Disease in Barbados,” addresses one of the most pressing and underexplored […]

The German Federal Ministry of Research, Technology, and Space is providing €2.8 million in funding for an interdisciplinary scientific consortium with the aim of making cycle apps for determining a woman’s fertile and infertile days significantly more reliable by taking biological markers into account. Researchers from the universities and university hospitals of Düsseldorf, Hamburg, and […]

Ladenburg, Germany, 29 January 2026 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that it has received a milestone payment under the terms of its license agreement with partner Takeda based on the achievement of a clinical development milestone for Takeda’s investigational medicine that utilizes […]

Scientists receive Proof of Concept Grants to develop the application potential of their research results In order to develop the application potential of their research results, Prof. Dr Hellmut Augustin and Prof. Dr Michael Platten are receiving funding from the European Research Council (ERC) that the ERC makes available as Proof of Concept Grants. Hellmut Augustin […]

Heidelberg, January 28, 2026 – RHEACELL GmbH & Co. KG is continuing to expand its presence in Heidelberg and moved into a second location in the Pfaffengrund district in August last year. At the start of the year, the location is now also becoming visible to the outside world: this week, the company logo will […]